Oncternal Therapeutics Announces Reverse Stock Split

January 4, 2024

https://www.globenewswire.com/news-release/2024/01/04/2804028/0/en/Oncternal-Therapeutics-Announces-Reverse-Stock-Split.html

SAN DIEGO, Jan. 04, 2024 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq:ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that its board of directors (Board) has approved a 1-for-20 reverse stock split of the company’s common stock. The reverse stock split will become effective at 12:01 a.m. Eastern time on January 8, 2024. The company’s common stock is expected to begin trading on a split-adjusted basis on The Nasdaq Capital Market under the same symbol (ONCT) when the market opens on January 8, 2024 with the new CUSIP number 68236P206.

Read more at globenewswire.com

Related news for (ONCT)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.